EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Selenium-Thioredoxin Axis Contributes to Ferroptosis Resistance in Pancreatic Cancer Cells

Arslan Amer, Micah Idowu iD, Aqsa Ahsan, Alyssa Abbas, Tahiyat Alothaim, Xiaohu Tang

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27042062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Arslan Amer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Michigan Technological University, Houghton, MI 49931, USA. Hauptthemen laut MEDLINE: Ferroptosis, Pancreatic Neoplasms, Selenium, Carcinoma, Pancreatic Ductal. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) shows substantial heterogeneity in cysteine dependence and ferroptosis sensitivity. We identify two PDAC subtypes distinguished by EMT status: mesenchymal-like cells are highly cysteine-dependent and rapidly undergo ferroptosis upon cystine deprivation or system xc− inhibition, whereas epithelial-type cells are ferroptosis-resistant. Selenium supplementation protects cells from erastin-induced ferroptosis, and this protection persists even when intracellular glutathione (GSH) is depleted, supporting an additional GPX4-independent protective mechanism. Sepp1 knockdown does not alter sensitivity, indicating that selenium’s protective effect is independent of Sepp1. Instead, epithelial-type cells rely on both cytosolic and mitochondrial thioredoxin reductases (TrxR1 and TrxR2) to maintain ferroptosis resistance. Chemical inhibition of thioredoxin reductases abolishes selenium-mediated protection and sensitizes epithelial cells to ferroptosis inducers, while dual genetic suppression of TrxR1 and TrxR2 similarly restores ferroptosis sensitivity. These findings uncover a selenium–thioredoxin redox axis that functions independently of GPX4 and contributes ferroptosis resistance in epithelial-type PDAC cells. Co-targeting cysteine metabolism and thioredoxin reductases may therefore represent a rational strategy to overcome ferroptosis resistance in some PDAC subtypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisPancreatic NeoplasmsSeleniumCarcinoma, Pancreatic DuctalThioredoxinsHumansCell Line, TumorCysteineThioredoxin Reductase 1GlutathioneThioredoxin Reductase 2Phospholipid Hydroperoxide Glutathione Peroxidase

Stichwörter der Autor:innen

EMTPDACferroptosisresistanceseleniumthioredoxin

Substanzen

SeleniumThioredoxinsCysteineThioredoxin Reductase 1GlutathioneThioredoxin Reductase 2Phospholipid Hydroperoxide Glutathione Peroxidase

Autor:innen und Institutionen

  • Department of Biological Sciences, Michigan Technological University, Houghton, MI 49931, USA.

ORCID-Profile: Micah Idowu

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Amer, A., Idowu, M., Ahsan, A., Abbas, A., Alothaim, T., & Tang, X. (2026). Selenium-Thioredoxin Axis Contributes to Ferroptosis Resistance in Pancreatic Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27042062

Vancouver

Amer A, Idowu M, Ahsan A, Abbas A, Alothaim T, Tang X. Selenium-Thioredoxin Axis Contributes to Ferroptosis Resistance in Pancreatic Cancer Cells. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27042062

BibTeX
@article{Amer2026,
  author = {Amer, Arslan and Idowu, Micah and Ahsan, Aqsa and Abbas, Alyssa and Alothaim, Tahiyat and Tang, Xiaohu},
  title = {Selenium-Thioredoxin Axis Contributes to Ferroptosis Resistance in Pancreatic Cancer Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27042062}
}
Kostenlos starten →